Outstanding results for Eurocine Vaccines´ mRNA based HSV-2 candidate

/PRNewswire/ -- As communicated earlier, Eurocine Vaccines is conducting preclinical trials to evaluate the mRNA and protein technology platforms for its...

Related Keywords

Sweden ,Solna ,Stockholm ,Swedish ,Hans Arwidsson ,Karl Ljungberg ,Preclinical Development At Eurocine Vaccines ,Eurocine Vaccines ,Preclinical Development ,